DNA Link
Private Company
Total funding raised: $20.8M
Overview
JS Link Sequencing Lab is a long-established, revenue-generating service provider in the genomics sector, operating as a business unit of JS Link Inc. With over two decades of experience, it serves a global clientele of over 600 researchers across 50 countries, offering sequencing and analysis on all major platforms including PacBio, Illumina, and 10x Genomics. The company's value proposition is built on technological breadth, proven track record, competitive pricing, and rapid turnaround times, positioning it as a key enabler for academic and research institutions tackling complex genomic studies.
Technology Platform
Multi-platform sequencing and genomic analysis infrastructure including PacBio Revio (long-read), Illumina NovaSeq X/6000 (short-read), 10x Genomics Chromium X (single-cell), ThermoFisher GeneTitan (microarray), and Quanterix Simoa (protein detection).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded genomics services market competing against large global CROs (e.g., Azenta, Charles River), sequencing platform vendors' own services (e.g., Illumina), and numerous regional/academic core facilities. Differentiation is based on technological breadth, long track record, and tailored analysis solutions for complex projects.